Medpace Holdings, Inc.

Global CRO providing full-service clinical development to biotech, pharma & medical device industries.

MEDP | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 5375 MEDPACE WAY, 45227 CINCINNATI
Website:: https://investor.medpace.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO). It provides comprehensive Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company's mission is to accelerate the development of safe and effective medical therapeutics through a disciplined operating approach. Key services include study strategy, clinical trial management, regulatory support, data management, and integrated laboratory services such as central lab, bioanalytical, ECG, and imaging core labs. Medpace leverages therapeutic expertise across major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system (CNS), and anti-viral/anti-infective diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Medpace Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medpace Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Medpace Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
AngioLab, Inc. Develops anti-angiogenic therapeutics and foods for angiogenesis-related diseases.	South Korea	251280
Anixa Biosciences Inc Clinical-stage biotech developing CAR-T immunotherapies and vaccines to fight cancer.	United States of America	ANIX
Annovis Bio, Inc. Developing oral therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.	United States of America	ANVS
Aoyama Zaisan Networks Company,Limited Consulting on inheritance and business succession for individuals and corporations.	Japan	8929
APG SGA SA Switzerland's leading OOH media firm offering digital and analogue outdoor advertising solutions.	Switzerland	APGN.SW
APURES CO., LTD. Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.	South Korea	149300
ARM HOLDINGS PLC /UK Licenses energy-efficient CPU IP for AI, mobile, automotive, IoT, and cloud markets.	United States of America	ARM
Arterra Bioscience Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.	Italy	ABS
ARVINAS, INC. Develops protein degradation drugs for oncology & neuroscience, targeting undruggable proteins.	United States of America	ARVN
ASUA Inc. Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.	Japan	246A